We use cookies to improve site performance and enhance your user experience. If you'd like to disable cookies on this device, please see our cookie management page.
If you close this message or continue to use this site, you consent to our use of cookies on this devise in accordance with our cookie policy, unless you disable them.


registration required

for more website access

This content can only be viewed by subscribers and registered users of Investors Chronicle.

Subscribe or register free today

Tissue Regenix poised for US launch

Investors have pushed shares in Tissue Regenix (TRX) up by about 150 per cent over the past nine months in anticipation of a now imminent product launch. The medical devices company is preparing to start selling its DermaPure product - aimed at treating chronic wounds - before the end of July.

registration required

visible-status-Subscription-Only story-url-Tissue Regenix full year results 19 May 2014.xml

By Harriet Russell,
20 May 2014

Print this article

Related Companies

Advertiser reports

Register today and get...

Register today and get...
Please note terms & conditions apply